Drugs / L. lactis CKDB001
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT07496021 Comparator | Feb 2026 → May 2027 expected | Alzheimer disease | CKD Bio Corporation | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L. lactis CKDB001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07496021 ↗ |
| Route | Oral | “Oral Capsule” NCT07496021 ↗ |